MacroGenics
MGNX
147 hedge funds and large institutions have $1.23B invested in MacroGenics in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 64 increasing their positions, 35 reducing their positions, and 15 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
83% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 35
53% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 15
6% more funds holding
Funds holding: 139 → 147 (+8)
3.98% less ownership
Funds ownership: 99.68% → 95.7% (-4%)
7% less capital invested
Capital invested by funds: $1.33B → $1.23B (-$97.7M)
52% less call options, than puts
Call options by funds: $1.76M | Put options by funds: $3.67M
Top Buyers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$28.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$24.6M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$14.3M |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$10.6M |
| 5 |
BlackRock
New York
|
+$7.44M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$49.2M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$33.3M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$33.1M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$6.24M |
| 5 |
ACM
Atika Capital Management
New York
|
-$5.11M |
MGNX Hedge Fund Activity: Q4 2020 in Review
147 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2020, worth a combined $1.23B — down 7.4% from $1.33B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new MGNX positions and 15 closed out — a net gain of 8 holders — while 64 added to existing stakes and 35 trimmed.
The largest buyer was Wasatch Advisors, adding an estimated $28.5M. The largest seller was Point72 Asset Management, cutting an estimated $49.2M.
- 147 institutional investors held MacroGenics (MGNX) as of Q4 2020, up from 139 in Q3 2020.
- Funds reported $1.23B of MacroGenics stock for Q4 2020, down 7.4% quarter-over-quarter.
- 23 funds opened new MacroGenics positions in Q4 2020 and 15 closed out, a net change of +8 holders.
- The largest MacroGenics buyer in Q4 2020 was Wasatch Advisors, an estimated $28.5M added.
- The largest MacroGenics seller in Q4 2020 was Point72 Asset Management, an estimated $49.2M sold.
Based on aggregated 13F filings for Q4 2020.